Navigation Links
Stanford scientists find molecule to starve lung cancer and improve ventilator recovery
Date:7/6/2012

Bethesda, MDA new research report published online in the FASEB Journal reveals a connection among sugar, cancer, and dependence on breathing machines--microRNA-320a. In the report, Stanford scientists show that the molecule microRNA-320a is responsible for helping control glycolysis. Glycolysis is the process of converting sugar into energy, which fuels the growth of some cancers, and contributes to the wasting of unused muscles such as the diaphragm when people are using ventilators. Identifying ways to use microRNA-320a to starve tumors and keep unused muscles strong would represent a significant therapeutic leap for numerous diseases and health conditions.

"We hope that this discovery will yield a new avenue of molecular treatment for cancers, particularly lung cancer, which is the number one cause of cancer deaths worldwide," said Joseph B. Shrager, M.D., a researcher involved in the work who is a Professor of Cardiothoracic Surgery, and Chief of the Division of Thoracic Surgery at Stanford University School of Medicine, and VA Palo Alto Healthcare System in California. "We also hope it can lead to a treatment to be given to intensive care unit patients who require the breathing machine, reducing the length of time they require the machine, and thereby reducing complications and deaths."

To make this discovery, Shrager and colleagues studied lung cancer tissues from patients and tissue from the diaphragm (the primary muscle used for breathing) from patients who had been on a breathing machine for more than a few hours. They found that both types of tissue had increases in glycolysis, as well as reductions in a molecule that controls glycolysismicroRNA-320a. Test tube experiments then showed that microRNA-320a definitely controls how much energy these two very different tissues have available to them.

"Just as the discovery of angiogenesis opened new doors to find w
'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Stanford marine biologist Barbara Block wins Rolex Award for Enterprise
2. Stanford researchers help predict the oceans of the future with a mini-lab
3. Stanford scientists document fragile land-sea ecological chain
4. Support for climate change action drops, Stanford poll finds
5. Americas clean energy policies need a reality check, say Stanford researchers
6. Stanford and MIT scientists win Perl-UNC Neuroscience prize
7. Climate change may create price volatility in the corn market, say Stanford and Purdue researchers
8. Keck award enables Carnegie Mellon and Stanford to dramatically expand crowdsourced RNA design
9. Stanford scientists develop gene therapy approach to grow blood vessels in ischemic limbs
10. Scripps Florida scientists identify critical quality control for cell growth
11. Gladstone scientists identify critical process in stem cell development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... by researchers at the University of Warwick in the ... published in the Journal Early Human Development , ... in hospital after birth and the use of mechanical ... preterm children. , Mathematic abilities are crucial for lifelong ... very preterm children. Earlier studies of children who are ...
(Date:9/2/2014)... breast milk is considered the most ideal source ... played a critical role in the evolution and ... human milk contains a large number of bacterial ... phenomenon comes as no surprise to scientists and ... is considered to be the result of co-evolutionary ...
(Date:9/2/2014)... In the battle between our immune systems and ... bacteria-killing viruses known as phages. In a new study, ... Health, Haiti,s National Public Health Laboratory, and elsewhere, report ... their virulence in order to survive. Importantly, the study ... cholera,s mutational escape from phage predation occurs during human ...
Breaking Biology News(10 mins):Mechanical ventilation a key indicator for pre-term children's math problems 2Are human breast milk microbiome 'neutral'? 2Are human breast milk microbiome 'neutral'? 3War between bacteria and phages benefits humans 2War between bacteria and phages benefits humans 3
... Medicine (BUSM) have brought attention to the potential health impacts ... brown seaweed soup. Seaweed is a known source of dietary ... on the iodine content in Korean seaweed soup. Written ... Thyroid and published online, the authors discuss the adverse ...
... investigation into the underlying causes of sudden cardiac death (SCD) ... the United States researchers have discovered a variation in ... increase in a person,s risk of SCD. The new ... region along the genome containing three genes previously unknown to ...
... useful strategy for helping prevent the development of panic and ... with an intense fear of the nausea, racing heart, dizziness, ... known as "high anxiety sensitivity" reacted with less anxiety ... high levels of physical activity, said researchers at Southern Methodist ...
Cached Biology News:BUSM researchers urge awareness of dietary iodine intake in postpartum Korean-American women 2Johns Hopkins researchers identify new genetic risk factor for sudden cardiac death 2Study: People at risk for panic buffered from stressor by high levels of physical activity 2Study: People at risk for panic buffered from stressor by high levels of physical activity 3
(Date:9/2/2014)... MA (PRWEB) September 02, 2014 ... today the signage of a distribution agreement with ... is now distributing Myriant’s bio-succinic acid in the ... and Ireland, targeting customers in the industrial and ... distribution powerhouse, Azelis offers a far-reaching chemical portfolio ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014 ... announced that the U.S. Patent and Trademark Office (PTO) ... investigational medication being evaluated for weight loss. NB32 is ... bupropion SR. U.S. Patent No. 8,815,889 claims ... naltrexone and bupropion. The patent expires in 2024. If ...
(Date:9/2/2014)... Sept. 2, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY ... and Chief Executive Officer, will present at the Rodman & ... New York on Tuesday, Sept. 9, 2014 ... archived webcast of the presentation will be accessible by visiting ... Events" section. About Oncothyreon ...
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... $2.1 million. The orders consist of three large odour control ... . "These orders are consistent with the ... Peter Bruijns , President and CEO. "After a difficult ... we are now beginning to see sales growth. Our lower ...
Breaking Biology Technology:Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 2Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 3Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent 4
... DCGN ) announced that on February 2, 2009, ... (the "Panel") stating that the Panel,will transfer the listing ... the Nasdaq Capital Market, effective at the open of ... Capital Market, which is,one of the three market tier ...
... Health,Inc. (Nasdaq: GHDX ) today reported financial results ... 31, 2008. , Total revenue for ... $19.3 million in the fourth quarter of 2007. Product ... in the fourth,quarter of 2008, an increase of 60 percent, ...
... Abt Associates announced that Ricky Takai, Ph.D., has ... brief orientation to the firm, Dr. Takai will become ... 2009. Dr. Takai brings his more than 20 ... evaluation studies in the field of education to the ...
Cached Biology Technology:deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market 2deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 2Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 3Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 4Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 5Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 6Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 7Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 8Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance 9Dr. Ricky Takai, Expert in Designing and Managing Federal Evaluation Studies in Education, Joins Abt Associates 2
... For nucleofection of optimized cell lines in ... the nucleofection parameters. Nucleofector Kits are only ... Different cell lines can be transfected with ... are given in brackets in percent (Efficiency ...
... Human Pathogenic Viruses The National ... preserves well characterised, authenticated human ... facility, and NCPV is able ... nucleic acids derived from them, ...
B-FABP (FL-132)...
... a highly purified preparation of the catalytic ... which recognizes the identical cleavage site as ... enzymatic activity (1). Novagen&'s enzyme is produced ... the highest activity available, and is qualified ...
Biology Products: